Decibel Therapeutics
Brendan Arsenault started working at Infinity Pharmaceuticals in 2007 as a Group Leader in Analytical Sciences. Brendan held this position until September 2016. In December 2016, they joined Decibel Therapeutics as a Scientist in Analytical Sciences.
Brendan Arsenault attended Boston College from 2003 to 2007, where they received a Bachelor of Science degree in Chemistry.
This person is not in the org chart
This person is not in any offices
Decibel Therapeutics
Decibel Therapeutics, a clinical-stage biotechnology company, has established the world’s first comprehensive drug discovery, development, and translational research platform for hearing and balance disorders.